miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod

BACKGROUND: Multiple sclerosis (MS) is a disabling autoimmune demyelinating disorder affecting young people and causing significant disability. In the last decade, different microRNA (miRNA) expression patterns have been associated to several treatment response therapies such as interferon and glati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Martinez, Alicia, Patel, Rohit, Healy, Brian C., Lokhande, Hrishikesh, Paul, Anu, Saxena, Shrishti, Polgar-Turcsanyi, Mariann, Weiner, Howard L., Chitnis, Tanuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227972/
https://www.ncbi.nlm.nih.gov/pubmed/37254147
http://dx.doi.org/10.1186/s12974-023-02811-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227972/
https://www.ncbi.nlm.nih.gov/pubmed/37254147
http://dx.doi.org/10.1186/s12974-023-02811-z

Ejemplares similares